Clinical Trials Logo
  1. Home
  2. Giant Cell Arteritis
  3. NCT04204512
  4. Details
NCT04204512 Clinical Trial

Comparison of 22Mhz and 18Mhz High-frequency Probes for the Ultrasound Study of Temporal Arteries in Patients Suspected of Having Giant Cell Arteritis

Giant Cell Arteritis Clinical Trial

— ECHORTON  

Official title:
Comparison of 2 Probes Frequencies in the Diagnosis of Giant Cell Arteritis

Clinical Trial Details — Status: Completed

Administrative data
NCT number NCT04204512
Other study ID # ECHORTON (29BRC19.0275)
Secondary ID
Status Completed
Phase
First received
Last updated
Start date December 17, 2019
Est. completion date August 24, 2020

Study information
Verified date July 2021
Source University Hospital, Brest
Contact n/a
Is FDA regulated No
Health authority
Study type Observational

Clinical Trial Summary

Evaluation of the structural features of temporal arteritis using two frequencies probes: 18 and 22Mhz.

Description:

Comparison of the results obtained by using 2 different frequencies probes in the diagnosis of giant cell arteritis

Recruitment information / eligibility
Status Completed
Enrollment 80
Est. completion date August 24, 2020
Est. primary completion date August 24, 2020
Accepts healthy volunteers No
Gender All
Age group 50 Years and older
Eligibility Inclusion Criteria: - sedimentation rate> 50 mm/h or recent unusual headache or unusual fever, recent visual trouble or jaw claudication, or induration temporal arteritis Exclusion Criteria: - previous diagnosis of giant cell arteritis and relapse of the giant cell arteritis and opposition to participate

Study Design

Related Conditions & MeSH terms

Locations
Country Name City State
France CHRU de Brest Brest

Sponsors (1)
Lead Sponsor Collaborator
University Hospital, Brest

Country where clinical trial is conducted

France, 

Outcome
Type Measure Description Time frame Safety issue
Primary halo sign of temporal arteritis hypoechogenicity of the wall artery inclusion
Primary compression sign of of temporal arteritis persistent of increased inflammatory arteries wall inclusion
Secondary halo sign of carotid arteritis hypoechogenicity of the wall artery inclusion
Secondary halo sign of subclavian arteritis hypoechogenicity of the wall artery inclusion
Secondary halo sign of axillary arteritis hypoechogenicity of the wall artery inclusion
Secondary other structural abnormalities in unilateral B mode stenosis, occlusion inclusion
Secondary other structural abnormalities in bilateral B mode stenosis, occlusion inclusion
See also
  Status Clinical Trial Phase
Completed NCT03812302 - Use of Gallium-68 HA-DOTATATE PET/CT in Giant Cell Arteritis (GCA) Phase 2
Recruiting NCT02257866 - Studies of the Natural History, Pathogenesis, and Outcome of Idiopathic Systemic Vasculitis
Recruiting NCT04888221 - Efficacy of Tocilizumab in Association to Steroids in Giant Cell Arteritis With Cerebro-vascular Involvement Phase 3
Recruiting NCT05380453 - Efficacy and Safety of Secukinumab in Patients With New Onset of Giant Cell Arteritis Who Are in Clinical Remission Phase 3
Recruiting NCT02333708 - Study of Circulating Microparticles in Giant Cell Arteritis
Completed NCT01450137 - Tocilizumab for Patients With Giant Cell Arteritis Phase 2
Completed NCT03827018 - KPL-301 for Subjects With Giant Cell Arteritis Phase 2
Active, not recruiting NCT04519580 - Improved Diagnostics and Monitoring of Polymyalgia Rheumatica
Recruiting NCT04239196 - Efficacy of Tocilizumab for the Treatment of Acute AION Related to GCA Phase 2
Completed NCT03202368 - An Extension Study to Evaluate Long-Term Safety of Subcutaneous (SC) Tocilizumab in Participants With Giant Cell Arteritis (GCA) Phase 3
Not yet recruiting NCT06004154 - Post-therapeutic Imaging Evaluation of Patients With Horton's Disease (Giant Cell Arteritis) (EvHortim)
Not yet recruiting NCT02523625 - Giant Cell Arteritis: Improving Use of Ultrasound Evaluation N/A
Completed NCT03285945 - FDG Uptake in Large-Vessel Giant Cell Arteritis After Short-term, High-Dose Steroid Treatment N/A
Completed NCT02190916 - Vasculitis Illness Perception (VIP) Study N/A
Recruiting NCT01241305 - One-Time DNA Study for Vasculitis
Terminated NCT02531633 - Efficacy and Safety Study of Sirukumab in Patients With Giant Cell Arteritis Phase 3
Completed NCT03409913 - Diagnostic Accuracy of FDG PET/CT of Cranial Arteries in GCA N/A
Completed NCT03765424 - Evaluation of Ultrasound and PET/CT in the Diagnosis and Monitoring of Giant Cell Arteritis
Completed NCT01910038 - Evaluation of Tocilizumab as an add-on Therapy to Corticoids in Giant Cell Arteritis: Proof of Concept Study. Phase 2
Not yet recruiting NCT04012905 - Giant Cell Arteritis: Comparison Between Two Standardized Corticosteroids Tapering Phase 3